Swissmedic

DHPC – Paxlovid® (Nirmatrelvir/Ritonavir)

Low obligation Product class Pharmaceuticals Switzerland Pharmacovigilance

20.07.2026

Read the official source ↗

Published by Swissmedic. HealthSignal links to the original document; the summary above is extracted from the source text.